Table 3.
UP in Fr | UP in F-DHJ | ||||||||
---|---|---|---|---|---|---|---|---|---|
Extracellular Matrix Genes | |||||||||
Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC | Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC |
205941_s_at | COL10A1 | collagen, type X, alpha 1 | 9.41 × 10−3 | 4.23 | 220518_at | ABI3BP | ABI family, member 3 (NESH) binding protein | 2.37 × 10−2 | 2.92 |
211343_s_at | COL13A1 | collagen, type XIII, alpha 1 | 1.44 × 10−2 | 2.26 | 1559077_at | ABI3BP | ABI family, member 3 (NESH) binding protein | 7.43 × 10−2 | 2.49 |
211809_x_at | COL13A1 | collagen, type XIII, alpha 1 | 2.74 × 10−2 | 1.74 | 222486_s_at | ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 2.76 × 10−2 | 2.33 |
221900_at | COL8A2 | collagen, type VIII, alpha 2 | 2.88 × 10−1 | 2.23 | 222162_s_at | ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 4.36 × 10−2 | 1.91 |
226824_at | CPXM2 | carboxypeptidase X (M14 family), member 2 | 2.01 × 10−1 | 1.88 | 226997_at | ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 3.75 × 10−3 | 2.78 |
221541_at | CRISPLD2 | cysteine-rich secretory protein LCCL domain containing 2 | 5.98 × 10−2 | 2.03 | 214913_at | ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | 1.94 × 10−2 | 1.94 |
206595_at | CST6 | cystatin E/M | 2.34 × 10−2 | 3.12 | 237411_at | ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | 1.36 × 10−1 | 1.61 |
225681_at | CTHRC1 | collagen triple helix repeat containing 1 | 1.31 × 10−2 | 2.82 | 224396_s_at | ASPN | asporin | 2.47 × 10−2 | 4.48 |
202450_s_at | CTSK | cathepsin K | 2.05 × 10−1 | 1.76 | 219087_at | ASPN | asporin | 1.32 × 10−2 | 3.54 |
213068_at | DPT | dermatopontin | 8.16 × 10−2 | 3.67 | 203477_at | COL15A1 | collagen, type XV, alpha 1 | 2.18 × 10−1 | 2.78 |
207977_s_at | DPT | dermatopontin | 1.24 × 10−1 | 2.85 | 209082_s_at | COL18A1 | collagen, type XVIII, alpha 1 | 6.56 × 10−4 | 2.99 |
222885_at | EMCN | endomucin | 6.59 × 10−2 | 2.74 | 209081_s_at | COL18A1 | collagen, type XVIII, alpha 1 | 3.92 × 10−3 | 2.83 |
227874_at | EMCN | endomucin | 2.70 × 10−1 | 1.81 | 208096_s_at | COL21A1 | collagen, type XXI, alpha 1 | 1.12 × 10−2 | 6.88 |
219436_s_at | EMCN | endomucin | 1.79 × 10−1 | 1.77 | 232458_at | COL3A1 | Collagen, type III, alpha 1 | 6.64 × 10−3 | 2.66 |
224374_s_at | EMILIN2 | elastin microfibril interfacer 2 | 6.75 × 10−2 | 1.68 | 211981_at | COL4A1 | collagen, type IV, alpha 1 | 2.12 × 10−3 | 1.93 |
203088_at | FBLN5 | fibulin 5 | 2.24 × 10−2 | 1.88 | 211980_at | COL4A1 | collagen, type IV, alpha 1 | 1.66 × 10−3 | 1.61 |
203638_s_at | FGFR2 | fibroblast growth factor receptor 2 | 3.21 × 10−3 | 4.52 | 222073_at | COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 2.28 × 10−2 | 1.70 |
208228_s_at | FGFR2 | fibroblast growth factor receptor 2 | 2.04 × 10−2 | 2.52 | 229779_at | COL4A4 | collagen, type IV, alpha 4 | 2.85 × 10−8 | 5.32 |
210187_at | FKBP1A | FK506 binding protein 1A, 12 kDa | 8.48 × 10−2 | 1.81 | 214602_at | COL4A4 | collagen, type IV, alpha 4 | 2.30 × 10−5 | 4.16 |
226145_s_at | FRAS1 | Fraser syndrome 1 | 6.34 × 10−2 | 2.31 | 213110_s_at | COL4A5 | collagen, type IV, alpha 5 | 1.05 × 10−1 | 3.62 |
204983_s_at | GPC4 | glypican 4 | 3.14 × 10−2 | 2.07 | 52255_s_at | COL5A3 | collagen, type V, alpha 3 | 2.47 × 10−3 | 3.07 |
204984_at | GPC4 | glypican 4 | 1.57 × 10−2 | 2.02 | 218975_at | COL5A3 | collagen, type V, alpha 3 | 2.83 × 10−3 | 2.65 |
235944_at | HMCN1 | hemicentin 1 | 3.52 × 10−5 | 6.28 | 205832_at | CPA4 | carboxypeptidase A4 | 2.37 × 10−2 | 4.34 |
203417_at | MFAP2 | microfibrillar-associated prot 2 | 8.08 × 10−2 | 1.70 | 201116_s_at | CPE | carboxypeptidase E | 7.11 × 10−3 | 2.37 |
204580_at | MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 2.58 × 10−1 | 2.17 | 201117_s_at | CPE | carboxypeptidase E | 4.90 × 10−3 | 2.10 |
205828_at | MMP3 | matrix metallopeptidase 3 | 4.79 × 10−3 | 7.70 | 227138_at | CRTAP | cartilage associated protein | 1.31 × 10−2 | 1.63 |
209596_at | MXRA5 | matrix-remodelling associated 5 | 2.09 × 10−2 | 2.52 | 201360_at | CST3 | cystatin C | 6.11 × 10−2 | 1.55 |
236088_at | NTNG1 | netrin G1 | 2.16 × 10−2 | 2.55 | 201487_at | CTSC | cathepsin C | 6.11 × 10−5 | 2.41 |
222722_at | OGN | osteoglycin | 1.91 × 10−1 | 2.04 | 225646_at | CTSC | cathepsin C | 1.80 × 10−3 | 2.32 |
228186_s_at | RSPO3 | R-spondin 3 homolog (X. laevis) | 1.35 × 10−2 | 2.98 | 225647_s_at | CTSC | cathepsin C | 1.37 × 10−3 | 2.25 |
218638_s_at | SPON2 | spondin 2, extracellular matrix prot | 3.07 × 10−2 | 2.84 | 231234_at | CTSC | cathepsin C | 5.72 × 10−3 | 2.03 |
216005_at | TNC | Tenascin C | 1.24 × 10−2 | 2.61 | 202295_s_at | CTSH | cathepsin H | 4.00 × 10−2 | 1.85 |
201645_at | TNC | tenascin C | 4.34 × 10−2 | 1.59 | 209335_at | DCN | decorin | 1.02 × 10−1 | 2.05 |
211896_s_at | DCN | decorin | 2.16 × 10−1 | 1.69 | |||||
211813_x_at | DCN | decorin | 1.52 × 10−1 | 1.68 | |||||
201893_x_at | DCN | decorin | 1.77 × 10−1 | 1.56 | |||||
1568779_a_at | ECM2 | extracellular matrix protein 2 | 1.76 × 10−1 | 1.71 | |||||
206101_at | ECM2 | extracellular matrix protein 2 | 2.50 × 10−1 | 1.57 | |||||
201843_s_at | EFEMP1 | EGF-containing fibulin-like extracellular matrix protein 1 | 7.68 × 10−4 | 3.62 | |||||
201842_s_at | EFEMP1 | EGF-containing fibulin-like extracellular matrix protein 1 | 4.62 × 10−4 | 2.87 | |||||
228421_s_at | EFEMP1 | EGF-containing fibulin-like extracellular matrix protein 1 | 2.23 × 10−1 | 1.61 | |||||
226911_at | EGFLAM | EGF-like, fibronectin type III and laminin G domains | 3.95 × 10−3 | 4.36 | |||||
204834_at | FGL2 | fibrinogen-like 2 | 4.12 × 10−4 | 6.37 | |||||
227265_at | FGL2 | fibrinogen-like 2 | 4.28 × 10−3 | 3.56 | |||||
202709_at | FMOD | fibromodulin | 1.12 × 10−3 | 2.96 | |||||
205206_at | KAL1 | Kallmann syndrome 1 sequence | 9.65 × 10−4 | 7.84 | |||||
227048_at | LAMA1 | laminin, alpha 1 | 2.82 × 10−1 | 1.83 | |||||
216840_s_at | LAMA2 | laminin, alpha 2 | 5.17 × 10−3 | 2.80 | |||||
205116_at | LAMA2 | laminin, alpha 2 | 1.05 × 10−2 | 2.67 | |||||
213519_s_at | LAMA2 | laminin, alpha 2 | 1.10 × 10−2 | 2.57 | |||||
210150_s_at | LAMA5 | laminin, alpha 5 | 4.86 × 10−2 | 1.57 | |||||
211651_s_at | LAMB1 | laminin, beta 1 | 8.27 × 10−2 | 1.54 | |||||
200770_s_at | LAMC1 | laminin, gamma 1 (formerly LAMB2) | 7.61 × 10−6 | 1.91 | |||||
200771_at | LAMC1 | laminin, gamma 1 (formerly LAMB2) | 7.75 × 10−7 | 1.90 | |||||
202267_at | LAMC2 | laminin, gamma 2 | 7.41 × 10−4 | 10.0 | |||||
200923_at | LGALS3BP LOC100133842 | lectin, galactoside-binding, soluble, 3 binding protein similar to lectin, galactoside-binding, soluble, 3 binding protein | 1.02 × 10−2 | 2.45 | |||||
242767_at | LMCD1 | LIM and cysteine-rich domains 1 | 1.72 × 10−2 | 2.01 | |||||
202998_s_at | LOXL2 | lysyl oxidase-like 2 | 4.16 × 10−3 | 1.59 | |||||
227145_at | LOXL4 | lysyl oxidase-like 4 | 3.15 × 10−2 | 2.43 | |||||
219922_s_at | LTBP3 | latent transforming growth factor beta binding protein 3 | 7.19 × 10−2 | 1.64 | |||||
227308_x_at | LTBP3 | latent transforming growth factor beta binding protein 3 | 2.22 × 10−3 | 1.53 | |||||
213765_at | MFAP5 | microfibrillar associated prot 5 | 3.51 × 10−3 | 1.61 | |||||
213764_s_at | MFAP5 | microfibrillar associated prot 5 | 3.23 × 10−3 | 1.53 | |||||
210605_s_at | MFGE8 | milk fat globule-EGF factor 8 protein | 1.80 × 10−1 | 1.75 | |||||
202291_s_at | MGP | matrix Gla protein | 3.10 × 10−4 | 7.14 | |||||
207847_s_at | MUC1 | mucin 1, cell surface associated | 1.58 × 10−1 | 2.38 | |||||
213693_s_at | MUC1 | mucin 1, cell surface associated | 2.03 × 10−2 | 2.04 | |||||
204114_at | NID2 | nidogen 2 (osteonidogen) | 2.32 × 10−3 | 2.83 | |||||
223315_at | NTN4 | netrin 4 | 1.76 × 10−4 | 14.27 | |||||
201860_s_at | PLAT | plasminogen activator, tissue | 2.56 × 10−2 | 2.15 | |||||
211668_s_at | PLAU | plasminogen activator, urokinase | 2.43 × 10−1 | 1.99 | |||||
228224_at | PRELP | proline/arginine-rich end leucine-rich repeat protein | 2.74 × 10−2 | 3.46 | |||||
204223_at | PRELP | proline/arginine-rich end leucine-rich repeat protein | 3.27 × 10−2 | 3.27 | |||||
205923_at | RELN | reelin | 3.58 × 10−8 | 9.15 | |||||
202376_at | SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 6.25 × 10−2 | 2.05 | |||||
204614_at | SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 9.41 × 10−2 | 5.27 | |||||
209723_at | SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 5.41 × 10−3 | 2.25 | |||||
200986_at | SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 2.27 × 10−1 | 1.72 | |||||
205352_at | SERPINI1 | serpin peptidase inhibitor, clade I (neuroserpin), member 1 | 1.54 × 10−3 | 2.71 | |||||
213493_at | SNED1 | sushi, nidogen and EGF-like domains 1 | 3.24 × 10−2 | 2.47 | |||||
213488_at | SNED1 | sushi, nidogen and EGF-like domains 1 | 2.30 × 10−1 | 1.94 | |||||
205236_x_at | SOD3 | superoxide dismutase 3, extracellular | 1.15 × 10−1 | 1.71 | |||||
202363_at | SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 5.31 × 10−3 | 2.13 | |||||
201858_s_at | SRGN | serglycin | 3.34 × 10−4 | 8.11 | |||||
201859_at | SRGN | serglycin | 3.81 × 10−4 | 4.87 | |||||
219552_at | SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 1.07 × 10−1 | 1.70 | |||||
213247_at | SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 6.04 × 10−2 | 1.70 | |||||
226506_at | THSD4 | thrombospondin, type I, domain containing 4 | 6.68 × 10−4 | 3.97 | |||||
222835_at | THSD4 | thrombospondin, type I, domain containing 4 | 5.26 × 10−5 | 3.43 | |||||
219058_x_at | TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 8.12 × 10−3 | 2.50 | |||||
216333_x_at | TNXA TNXB |
tenascin XA pseudogene tenascin XB | 7.97 × 10−5 | 11.18 | |||||
206093_x_at | TNXA TNXB |
tenascin XA pseudogene tenascin XB | 5.32 × 10−5 | 10.76 | |||||
213451_x_at | TNXA TNXB |
tenascin XA pseudogene tenascin XB | 1.65 × 10−4 | 9.71 | |||||
208609_s_at | TNXB | tenascin XB | 7.07 × 10−5 | 8.99 | |||||
Focal Adhesion Points | |||||||||
Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC | Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC |
205730_s_at | ABLIM3 | actin binding LIM protein family, member 3 | 1.06 × 10−1 | 1.53 | 200965_s_at | ABLIM1 | actin binding LIM protein 1 | 2.02 × 10−5 | 4.17 |
213497_at | ABTB2 | ankyrin repeat and BTB (POZ) domain containing 2 | 6.59 × 10−2 | 1.61 | 205882_x_at | ADD3 | adducin 3 (gamma) | 6.45 × 10−3 | 1.59 |
205268_s_at | ADD2 | adducin 2 (beta) | 8.16 × 10−4 | 7.50 | 201752_s_at | ADD3 | adducin 3 (gamma) | 9.71 × 10−3 | 1.56 |
205771_s_at | AKAP7 | A kinase (PRKA) anchor prot 7 | 1.03 × 10−1 | 1.58 | 227529_s_at | AKAP12 | A kinase (PRKA) anchor prot 12 | 6.81 × 10−3 | 8.03 |
205257_s_at | AMPH | amphiphysin | 1.45 × 10−7 | 6.02 | 227530_at | AKAP12 | A kinase (PRKA) anchor prot 12 | 4.43 × 10−3 | 6.10 |
1552619_a_at | ANLN | anillin, actin binding protein | 3.48 × 10−2 | 2.47 | 210517_s_at | AKAP12 | A kinase (PRKA) anchor prot 12 | 6.53 × 10−3 | 4.66 |
222608_s_at | ANLN | anillin, actin binding protein | 4.60 × 10−2 | 2.25 | 202920_at | ANK2 | ankyrin 2, neuronal | 8.40 × 10−3 | 2.34 |
203526_s_at | APC | adenomatous polyposis coli | 3.34 × 10−3 | 1.60 | 206385_s_at | ANK3 | ankyrin 3, node of Ranvier (ankyrin G) | 3.69 × 10−3 | 3.16 |
204492_at | ARHGAP11A | Rho GTPase activating protein 11A | 3.11 × 10−2 | 2.12 | 227337_at | ANKRD37 | ankyrin repeat domain 37 | 4.35 × 10−6 | 6.04 |
37577_at | ARHGAP19 | Rho GTPase activating protein 19 | 9.72 × 10−4 | 1.72 | 204671_s_at | ANKRD6 | ankyrin repeat domain 6 | 3.20 × 10−2 | 2.12 |
206298_at | ARHGAP22 | Rho GTPase activating protein 22 | 8.57 × 10−3 | 1.58 | 204672_s_at | ANKRD6 | ankyrin repeat domain 6 | 5.69 × 10−2 | 1.96 |
201288_at | ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 3.85 × 10−2 | 1.54 | 228368_at | ARHGAP20 | Rho GTPase activating prot 20 | 1.15 × 10−4 | 5.72 |
204092_s_at | AURKA | aurora kinase A | 2.07 × 10−2 | 2.88 | 227911_at | ARHGAP28 | Rho GTPase activating prot 28 | 1.07 × 10−3 | 2.38 |
208079_s_at | AURKA | aurora kinase A | 3.80 × 10−2 | 2.45 | 206167_s_at | ARHGAP6 | Rho GTPase activating prot 6 | 1.09 × 10−1 | 1.65 |
209464_at | AURKB | aurora kinase B | 1.04 × 10−2 | 2.92 | 205109_s_at | ARHGEF4 | Rho guanine nucleotide exchange factor (GEF) 4 | 1.49 × 10−1 | 1.53 |
205294_at | BAIAP2 | BAI1-associated protein 2 | 2.67 × 10−3 | 1.51 | 201615_x_at | CALD1 | caldesmon 1 | 1.61 × 10−1 | 1.79 |
210334_x_at | BIRC5 | baculoviral IAP repeat-containing 5 | 1.01 × 10−2 | 2.69 | 201616_s_at | CALD1 | caldesmon 1 | 1.89 × 10−2 | 1.53 |
202094_at | BIRC5 | baculoviral IAP repeat-containing 5 | 4.10 × 10−2 | 2.63 | 236473_at | CC2D2A | coiled-coil and C2 domain containing 2A | 2.18 × 10−3 | 2.56 |
202095_s_at | BIRC5 | baculoviral IAP repeat-containing 5 | 1.72 × 10−2 | 2.47 | 203139_at | DAPK1 | death-associated protein kinase 1 | 2.66 × 10−2 | 3.97 |
220935_s_at | CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | 1.91 × 10−7 | 1.78 | 229800_at | DCLK1 | Doublecortin-like kinase 1 | 1.78 × 10−1 | 1.99 |
204962_s_at | CENPA | centromere protein A | 3.83 × 10−2 | 2.88 | 217208_s_at | DLG1 | discs, large homolog 1 (Drosophila) | 6.19 × 10−3 | 2.32 |
210821_x_at | CENPA | centromere protein A | 4.21 × 10−3 | 1.98 | 202515_at | DLG1 | discs, large homolog 1 (Drosophila) | 1.59 × 10−3 | 1.72 |
205046_at | CENPE | centromere protein E, 312 kDa | 7.08 × 10−2 | 2.65 | 202514_at | DLG1 | discs, large homolog 1 (Drosophila) | 6.69 × 10−3 | 1.72 |
209172_s_at | CENPF | centromere protein F, 350/400 ka (mitosin) | 1.33 × 10−2 | 2.98 | 230229_at | DLG1 | Discs, large homolog 1 (Drosophila) | 1.49 × 10−1 | 1.63 |
207828_s_at | CENPF | centromere protein F, 350/400 ka (mitosin) | 2.29 × 10−2 | 2.94 | 202516_s_at | DLG1 | discs, large homolog 1 (Drosophila) | 5.92 × 10−2 | 1.60 |
231772_x_at | CENPH | centromere protein H | 2.74 × 10−2 | 1.82 | 203881_s_at | DMD | dystrophin | 1.06 × 10−4 | 5.02 |
214804_at | CENPI | centromere protein I | 5.29 × 10−2 | 1.96 | 208086_s_at | DMD | dystrophin | 2.36 × 10−2 | 1.58 |
207590_s_at | CENPI | centromere protein I | 1.62 × 10−2 | 1.88 | 227081_at | DNALI1 | dynein, axonemal, light intermediate chain 1 | 2.64 × 10−2 | 1.64 |
223513_at | CENPJ | centromere protein J | 2.83 × 10−2 | 1.69 | 226875_at | DOCK11 | dedicator of cytokinesis 11 | 4.24 × 10−4 | 1.78 |
222848_at | CENPK | centromere protein K | 1.00 × 10−1 | 1.94 | 1554863_s_at | DOK5 | docking protein 5 | 1.93 × 10−2 | 1.59 |
1554271_a_at | CENPL | centromere protein L | 1.69 × 10−1 | 1.54 | 214844_s_at | DOK5 | docking protein 5 | 2.98 × 10−3 | 1.52 |
218741_at | CENPM | centromere protein M | 1.86 × 10−2 | 2.36 | 220161_s_at | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 5.64 × 10−2 | 2.33 |
219555_s_at | CENPN | centromere protein N | 9.25 × 10−3 | 1.89 | 209829_at | FAM65B | family with sequence similarity 65, member B | 3.97 × 10−2 | 2.58 |
222118_at | CENPN | centromere protein N | 1.24 × 10−1 | 1.84 | 206707_x_at | FAM65B | family with sequence similarity 65, member B | 3.02 × 10−2 | 2.20 |
228559_at | CENPN | centromere protein N | 8.63 × 10−2 | 1.74 | 226129_at | FAM83H | family with sequence similarity 83, member H | 2.04 × 10−2 | 1.75 |
226118_at | CENPO | centromere protein O | 6.22 × 10−2 | 1.78 | 227948_at | FGD4 | FYVE, RhoGEF and PH domain containing 4 | 9.89 × 10−4 | 3.94 |
219294_at | CENPQ | centromere protein Q | 5.50 × 10−2 | 1.56 | 230559_x_at | FGD4 | FYVE, RhoGEF and PH domain containing 4 | 3.65 × 10−3 | 2.66 |
205642_at | CEP110 | centrosomal protein 110 kDa | 6.59 × 10−3 | 1.87 | 225167_at | FRMD4A | FERM domain containing 4A | 1.45 × 10−2 | 2.04 |
239413_at | CEP152 | centrosomal protein 152 kDa | 3.34 × 10−3 | 1.71 | 225163_at | FRMD4A | FERM domain containing 4A | 8.39 × 10−3 | 1.98 |
218542_at | CEP55 | centrosomal protein 55 kDa | 2.63 × 10−2 | 2.44 | 225168_at | FRMD4A | FERM domain containing 4A | 2.22 × 10−2 | 1.76 |
206324_s_at | DAPK2 | death-associated protein kinase 2 | 7.47 × 10−2 | 1.73 | 1560031_at | FRMD4A | FERM domain containing 4A | 1.07 × 10−3 | 1.71 |
227666_at | DCLK2 | doublecortin-like kinase 2 | 7.38 × 10−2 | 1.52 | 208476_s_at | FRMD4A | FERM domain containing 4A | 7.85 × 10−3 | 1.69 |
207147_at | DLX2 | distal-less homeobox 2 | 1.94 × 10−2 | 6.12 | 1554034_a_at | FRMD4A | FERM domain containing 4A | 2.32 × 10−1 | 1.57 |
215116_s_at | DNM1 | dynamin 1 | 2.03 × 10−4 | 3.83 | 239290_at | FRMPD4 | FERM and PDZ domain containing 4 | 1.74 × 10−1 | 1.56 |
219279_at | DOCK10 | dedicator of cytokinesis 10 | 2.60 × 10−2 | 1.66 | 203037_s_at | MTSS1 | metastasis suppressor 1 | 2.31 × 10−3 | 4.32 |
213160_at | DOCK2 | dedicator of cytokinesis 2 | 1.12 × 10−4 | 1.76 | 212096_s_at | MTUS1 | mitochondrial tumor supp 1 | 1.02 × 10−1 | 2.47 |
205003_at | DOCK4 | dedicator of cytokinesis 4 | 1.44 × 10−1 | 1.54 | 212095_s_at | MTUS1 | mitochondrial tumor supp 1 | 1.08 × 10−1 | 1.74 |
206710_s_at | EPB41L3 | erythrocyte membrane protein band 4.1-like 3 | 1.31 × 10−2 | 3.52 | 228098_s_at | MYLIP | myosin regulatory light chain interacting protein | 5.16 × 10−2 | 1.57 |
212681_at | EPB41L3 | erythrocyte membrane protein band 4.1-like 3 | 1.38 × 10−2 | 3.22 | 220319_s_at | MYLIP | myosin regulatory light chain interacting protein | 4.55 × 10−2 | 1.50 |
211776_s_at | EPB41L3 | erythrocyte membrane protein band 4.1-like 3 | 1.48 × 10−2 | 3.20 | 237206_at | MYOCD | myocardin | 8.62 × 10−3 | 3.85 |
218980_at | FHOD3 | formin homology 2 domain containing 3 | 7.93 × 10−3 | 3.13 | 213782_s_at | MYOZ2 | myozenin 2 | 8.68 × 10−2 | 2.16 |
238621_at | FMN1 | formin 1 | 6.44 × 10−3 | 2.47 | 207148_x_at | MYOZ2 | myozenin 2 | 8.91 × 10−2 | 2.07 |
1555471_a_at | FMN2 | formin 2 | 2.05 × 10−2 | 1.85 | 219073_s_at | OSBPL10 | oxysterol binding protein-like 10 | 3.31 × 10−2 | 2.11 |
223618_at | FMN2 | formin 2 | 2.05 × 10−2 | 1.82 | 209621_s_at | PDLIM3 | PDZ and LIM domain 3 | 8.38 × 10−2 | 3.31 |
215017_s_at | FNBP1L | formin binding protein 1-like | 3.68 × 10−3 | 1.52 | 213684_s_at | PDLIM5 | PDZ and LIM domain 5 | 6.28 × 10−3 | 1.87 |
230645_at | FRMD3 | FERM domain containing 3 | 2.69 × 10−1 | 1.63 | 221994_at | PDLIM5 | PDZ and LIM domain 5 | 2.46 × 10−3 | 1.81 |
230831_at | FRMD5 | FERM domain containing 5 | 1.02 × 10−2 | 2.87 | 203242_s_at | PDLIM5 | PDZ and LIM domain 5 | 1.86 × 10−3 | 1.68 |
238756_at | GAS2L3 | Growth arrest-specific 2 like 3 | 1.22 × 10−2 | 2.33 | 216804_s_at | PDLIM5 | PDZ and LIM domain 5 | 4.90 × 10−3 | 1.60 |
235709_at | GAS2L3 | growth arrest-specific 2 like 3 | 2.92 × 10−2 | 1.81 | 207717_s_at | PKP2 | plakophilin 2 | 2.96 × 10−2 | 3.09 |
226308_at | HAUS8 | HAUS augmin-like complex, subunit 8 | 3.75 × 10−2 | 1.71 | 201927_s_at | PKP4 | plakophilin 4 | 2.90 × 10−1 | 1.68 |
226364_at | HIP1 | Huntingtin interacting protein 1 | 1.05 × 10−3 | 2.73 | 227148_at | PLEKHH2 | pleckstrin homology domain containing, family H member 2 | 3.16 × 10−3 | 3.05 |
205425_at | HIP1 | huntingtin interacting protein 1 | 9.54 × 10−3 | 2.66 | 203407_at | PPL | periplakin | 7.99 × 10−3 | 3.20 |
218934_s_at | HSPB7 | heat shock 27 kDa protein family, member 7 (cardiovascular) | 7.51 × 10−2 | 2.16 | 226627_at | SEPT8 | septin 8 | 1.20 × 10−1 | 1.74 |
227750_at | KALRN | kalirin, RhoGEF kinase | 8.61 × 10−3 | 1.53 | 226438_at | SNTB1 | syntrophin, beta 1 (dystrophin-associated protein A1, 59 kDa, basic component 1) | 1.03 × 10−2 | 1.84 |
229125_at | KANK4 | KN motif and ankyrin repeat domains 4 | 1.76 × 10−2 | 3.51 | 214708_at | SNTB1 | syntrophin, beta 1 (dystrophin-associated protein A1, 59 kDa, basic component 1) | 3.83 × 10−2 | 1.53 |
204444_at | KIF11 | kinesin family member 11 | 4.00 × 10−2 | 2.43 | 227179_at | STAU2 | staufen, RNA binding protein, homolog 2 (Drosophila) | 1.58 × 10−2 | 1.89 |
236641_at | KIF14 | kinesin family member 14 | 1.15 × 10−2 | 3.50 | 212565_at | STK38L | serine/threonine kinase 38 like | 5.74 × 10−5 | 1.94 |
206364_at | KIF14 | kinesin family member 14 | 5.29 × 10−2 | 2.87 | 212572_at | STK38L | serine/threonine kinase 38 like | 5.09 × 10−3 | 1.53 |
219306_at | KIF15 | kinesin family member 15 | 1.87 × 10−2 | 2.65 | 202796_at | SYNPO | synaptopodin | 7.05 × 10−2 | 2.18 |
221258_s_at | KIF18A | kinesin family member 18A | 1.25 × 10−2 | 2.79 | 227662_at | SYNPO2 | synaptopodin 2 | 1.29 × 10−1 | 3.30 |
222039_at | KIF18B | kinesin family member 18B | 6.34 × 10−2 | 2.25 | 213135_at | TIAM1 | T-cell lymphoma invasion and metastasis 1 | 1.12 × 10−1 | 1.65 |
218755_at | KIF20A | kinesin family member 20A | 1.17 × 10−2 | 2.81 | 209904_at | TNNC1 | troponin C type 1 (slow) | 6.34 × 10−2 | 2.76 |
205235_s_at | KIF20B | kinesin family member 20B | 1.83 × 10−2 | 1.95 | 215389_s_at | TNNT2 | troponin T type 2 (cardiac) | 5.06 × 10−2 | 3.22 |
216969_s_at | KIF22 | kinesin family member 22 | 9.75 × 10−2 | 1.92 | 210276_s_at | TRIOBP | TRIO and F-actin binding prot | 6.96 × 10−2 | 1.52 |
202183_s_at | KIF22 | kinesin family member 22 | 6.19 × 10−3 | 1.65 | 223279_s_at | UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats | 6.84 × 10−3 | 1.79 |
204709_s_at | KIF23 | kinesin family member 23 | 3.68 × 10−2 | 2.55 | 238868_at | UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats | 1.37 × 10−1 | 1.66 |
244427_at | KIF23 | Kinesin family member 23 | 2.68 × 10−3 | 1.76 | |||||
209408_at | KIF2C | kinesin family member 2C | 3.86 × 10−2 | 2.95 | |||||
211519_s_at | KIF2C | kinesin family member 2C | 2.04 × 10−2 | 2.80 | |||||
218355_at | KIF4A | kinesin family member 4A | 3.29 × 10−2 | 2.60 | |||||
209680_s_at | KIFC1 | kinesin family member C1 | 1.72 × 10−2 | 2.43 | |||||
206316_s_at | KNTC1 | kinetochore associated 1 | 1.88 × 10−2 | 1.86 | |||||
224823_at | MYLK | myosin light chain kinase | 1.91 × 10−1 | 1.72 | |||||
236718_at | MYO10 | myosin X | 1.05 × 10−3 | 1.86 | |||||
244350_at | MYO10 | myosin X | 1.45 × 10−2 | 1.70 | |||||
241966_at | MYO5A | myosin VA (heavy chain 12, myoxin) | 2.21 × 10−2 | 1.51 | |||||
201774_s_at | NCAPD2 | non-SMC condensin I complex, subunit D2 | 1.30 × 10−1 | 1.57 | |||||
212789_at | NCAPD3 | non-SMC condensin II complex, subunit D3 | 5.55 × 10−2 | 1.56 | |||||
218663_at | NCAPG | non-SMC condensin I complex, subunit G | 1.03 × 10−1 | 2.23 | |||||
218662_s_at | NCAPG | non-SMC condensin I complex, subunit G | 8.24 × 10−2 | 2.11 | |||||
219588_s_at | NCAPG2 | non-SMC condensin II complex, subunit G2 | 2.03 × 10−2 | 1.86 | |||||
212949_at | NCAPH | non-SMC condensin I complex, subunit H | 3.01 × 10−2 | 2.58 | |||||
204641_at | NEK2 | NIMA (never in mitosis gene a)-related kinase 2 | 2.34 × 10−2 | 2.97 | |||||
211080_s_at | NEK2 | NIMA (never in mitosis gene a)-related kinase 2 | 4.89 × 10−3 | 2.64 | |||||
223381_at | NUF2 | NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) | 8.44 × 10−2 | 2.67 | |||||
219978_s_at | NUSAP1 | nucleolar and spindle associated protein 1 | 1.39 × 10−1 | 2.48 | |||||
218039_at | NUSAP1 | nucleolar and spindle associated protein 1 | 2.98 × 10−2 | 2.42 | |||||
204972_at | OAS2 | 2’-5’-oligoadenylate synthetase 2, 69/71 kDa | 2.83 × 10−1 | 1.68 | |||||
209626_s_at | OSBPL3 | oxysterol binding protein-like 3 | 5.77 × 10−2 | 1.67 | |||||
238575_at | OSBPL6 | oxysterol binding protein-like 6 | 1.17 × 10−2 | 2.13 | |||||
223805_at | OSBPL6 | oxysterol binding protein-like 6 | 9.15 × 10−3 | 2.09 | |||||
218644_at | PLEK2 | pleckstrin 2 | 4.94 × 10−3 | 2.63 | |||||
218009_s_at | PRC1 | protein regulator of cytokinesis 1 | 2.03 × 10−2 | 2.37 | |||||
222077_s_at | RACGAP1 | Rac GTPase activating protein 1 | 1.49 × 10−2 | 1.99 | |||||
219263_at | RNF128 | ring finger protein 128 | 2.50 × 10−2 | 3.03 | |||||
230730_at | SGCD | sarcoglycan, delta (35 kDa dystrophin-associated glycoprotein) | 2.17 × 10−2 | 3.65 | |||||
213543_at | SGCD | sarcoglycan, delta (35 kDa dystrophin-associated glycoprotein) | 2.12 × 10−2 | 3.57 | |||||
228602_at | SGCD | sarcoglycan, delta (35 kDa dystrophin-associated glycoprotein) | 6.41 × 10−2 | 3.55 | |||||
214492_at | SGCD | sarcoglycan, delta (35 kDa dystrophin-associated glycoprotein) | 5.41 × 10−3 | 3.18 | |||||
210329_s_at | SGCD | sarcoglycan, delta (35 kDa dystrophin-associated glycoprotein) | 8.64 × 10−3 | 2.72 | |||||
210330_at | SGCD | sarcoglycan, delta (35 kDa dystrophin-associated glycoprotein) | 3.47 × 10−2 | 2.43 | |||||
207302_at | SGCG | sarcoglycan, gamma (35 kDa dystrophin-associated glycoprotein) | 1.42 × 10−1 | 3.09 | |||||
217678_at | SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 7.43 × 10−2 | 1.53 | |||||
209921_at | SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 3.18 × 10−2 | 1.53 | |||||
1556583_a_at | SLC8A1 | solute carrier family 8 (sodium/calcium exchanger), member 1 | 1.96 × 10−1 | 1.85 | |||||
241752_at | SLC8A1 | solute carrier family 8 (sodium/calcium exchanger), member 1 | 2.94 × 10−1 | 1.61 | |||||
200783_s_at | STMN1 | stathmin 1 | 1.16 × 10−2 | 2.14 | |||||
222557_at | STMN3 | stathmin-like 3 | 1.48 × 10−2 | 1.83 | |||||
212703_at | TLN2 | talin 2 | 5.18 × 10−4 | 1.84 | |||||
206117_at | TPM1 | tropomyosin 1 (alpha) | 5.66 × 10−3 | 2.26 | |||||
210052_s_at | TPX2 | TPX2, microtubule-associated, homolog (Xenopus laevis) | 1.78 × 10−2 | 2.56 | |||||
1555938_x_at | VIM | vimentin | 2.81 × 10−2 | 2.00 | |||||
202663_at | WIPF1 | WAS/WASL interacting protein family, member 1 | 6.39 × 10−3 | 1.64 | |||||
202664_at | WIPF1 | WAS/WASL interacting protein family, member 1 | 5.61 × 10−4 | 1.58 | |||||
202665_s_at | WIPF1 | WAS/WASL interacting protein family, member 1 | 2.97 × 10−3 | 1.51 | |||||
Cytoskeleton | |||||||||
Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC | Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC |
205132_at | ACTC1 | actin, alpha, cardiac muscle 1 | 1.80 × 10−3 | 4.22 | 203563_at | AFAP1 | actin filament associated protein 1 | 2.27 × 10−3 | 1.90 |
230925_at | APBB1IP | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | 1.66 × 10−2 | 2.50 | 206488_s_at | CD36 | CD36 molecule (thrombospondin receptor) | 1.46 × 10−8 | 20.69 |
226292_at | CAPN5 | calpain 5 | 2.20 × 10−4 | 1.51 | 209555_s_at | CD36 | CD36 molecule (thrombospondin receptor) | 3.58 × 10−8 | 19.05 |
217523_at | CD44 | CD44 molecule (Indian blood group) | 1.89 × 10−2 | 1.64 | 228766_at | CD36 | CD36 molecule (thrombospondin receptor) | 2.97 × 10−6 | 11.94 |
220115_s_at | CDH10 | cadherin 10, type 2 (T2-cadherin) | 1.94 × 10−1 | 1.90 | 201005_at | CD9 | CD9 molecule | 7.82 × 10−4 | 2.58 |
207030_s_at | CSRP2 | cysteine and glycine-rich protein 2 | 1.93 × 10−2 | 1.74 | 201131_s_at | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 4.31 × 10−2 | 2.54 |
211126_s_at | CSRP2 | cysteine and glycine-rich protein 2 | 2.34 × 10−2 | 1.71 | 204726_at | CDH13 | cadherin 13, H-cadherin (heart) | 3.20 × 10−2 | 2.60 |
214724_at | DIXDC1 | DIX domain containing 1 | 1.14 × 10−2 | 1.53 | 203256_at | CDH3 | cadherin 3, type 1, P-cadherin (placental) | 3.21 × 10−2 | 1.84 |
202668_at | EFNB2 | ephrin-B2 | 1.85 × 10−1 | 3.24 | 200621_at | CSRP1 | cysteine and glycine-rich protein 1 | 1.70 × 10−2 | 1.56 |
205031_at | EFNB3 | ephrin-B3 | 2.95 × 10−10 | 2.47 | 203716_s_at | DPP4 | dipeptidyl-peptidase 4 | 4.05 × 10−2 | 1.93 |
1555480_a_at | FBLIM1 | filamin binding LIM protein 1 | 1.07 × 10−2 | 1.89 | 211478_s_at | DPP4 | dipeptidyl-peptidase 4 | 2.67 × 10−1 | 1.80 |
1554795_a_at | FBLIM1 | filamin binding LIM protein 1 | 2.26 × 10−2 | 1.61 | 203717_at | DPP4 | dipeptidyl-peptidase 4 | 1.08 × 10−1 | 1.67 |
225258_at | FBLIM1 | filamin binding LIM protein 1 | 2.87 × 10−3 | 1.56 | 227955_s_at | EFNA5 | ephrin-A5 | 4.68 × 10−2 | 1.94 |
204379_s_at | FGFR3 | fibroblast growth factor receptor 3 | 9.77 × 10−2 | 2.01 | 214036_at | EFNA5 | ephrin-A5 | 1.32 × 10−1 | 1.53 |
242592_at | GPR137C | G protein-coupled receptor 137C | 1.50 × 10−2 | 2.18 | 201983_s_at | EGFR | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 1.75 × 10−3 | 1.82 |
235961_at | GPR161 | G protein-coupled receptor 161 | 4.34 × 10−4 | 1.56 | 201809_s_at | ENG | endoglin | 2.31 × 10−3 | 2.06 |
230369_at | GPR161 | G protein-coupled receptor 161 | 3.44 × 10−2 | 1.53 | 201539_s_at | FHL1 | four and a half LIM domains 1 | 8.39 × 10−3 | 6.09 |
229055_at | GPR68 | G protein-coupled receptor 68 | 7.83 × 10−3 | 1.70 | 214505_s_at | FHL1 | four and a half LIM domains 1 | 6.48 × 10−3 | 5.76 |
234303_s_at | GPR85 | G protein-coupled receptor 85 | 7.25 × 10−2 | 2.04 | 210299_s_at | FHL1 | four and a half LIM domains 1 | 1.55 × 10−3 | 5.39 |
203632_s_at | GPRC5B | G protein-coupled receptor, family C, group 5, member B | 1.76 × 10−1 | 1.92 | 210298_x_at | FHL1 | four and a half LIM domains 1 | 6.70 × 10−3 | 5.18 |
222899_at | ITGA11 | integrin, alpha 11 | 1.21 × 10−2 | 1.59 | 201540_at | FHL1 | four and a half LIM domains 1 | 4.21 × 10−4 | 3.20 |
227314_at | ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 5.68 × 10−2 | 2.53 | 222853_at | FLRT3 | fibronectin leucine rich transmembrane protein 3 | 7.40 × 10−4 | 3.36 |
205032_at | ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 3.78 × 10−2 | 2.41 | 219250_s_at | FLRT3 | fibronectin leucine rich transmembrane protein 3 | 4.52 × 10−2 | 2.12 |
228080_at | LAYN | layilin | 4.84 × 10−3 | 2.59 | 212950_at | GPR116 | G protein-coupled receptor 116 | 1.98 × 10−1 | 3.52 |
216250_s_at | LPXN | leupaxin | 2.03 × 10−5 | 3.08 | 213094_at | GPR126 | G protein-coupled receptor 126 | 9.65 × 10−4 | 5.14 |
210869_s_at | MCAM | melanoma cell adhesion molecule | 1.03 × 10−6 | 7.67 | 232267_at | GPR133 | G protein-coupled receptor 133 | 1.46 × 10−2 | 2.44 |
209087_x_at | MCAM | melanoma cell adhesion molecule | 1.08 × 10−6 | 7.38 | 228949_at | GPR177 | G protein-coupled receptor 177 | 3.16 × 10−4 | 2.71 |
211340_s_at | MCAM | melanoma cell adhesion molecule | 1.07 × 10−6 | 6.81 | 228950_s_at | GPR177 | G protein-coupled receptor 177 | 3.49 × 10−3 | 2.63 |
209086_x_at | MCAM | melanoma cell adhesion molecule | 2.85 × 10−8 | 5.09 | 221958_s_at | GPR177 | G protein-coupled receptor 177 | 1.52 × 10−3 | 2.50 |
203062_s_at | MDC1 | mediator of DNA damage checkpoint 1 | 3.87 × 10−3 | 1.58 | 229105_at | GPR39 | G protein-coupled receptor 39 | 2.66 × 10−2 | 1.90 |
212843_at | NCAM1 | neural cell adhesion molecule 1 | 8.99 × 10−7 | 4.58 | 212070_at | GPR56 | G protein-coupled receptor 56 | 2.12 × 10−2 | 1.78 |
227394_at | NCAM1 | neural cell adhesion molecule 1 | 1.26 × 10−6 | 3.16 | 203108_at | GPRC5A | G protein-coupled receptor, family C, group 5, member A | 2.08 × 10−3 | 8.54 |
213438_at | NFASC | neurofascin homolog (chicken) | 3.12 × 10−2 | 2.57 | 202638_s_at | ICAM1 | intercellular adhesion molecule 1 | 1.31 × 10−1 | 2.21 |
230242_at | NFASC | neurofascin homolog (chicken) | 5.17 × 10−3 | 2.19 | 202637_s_at | ICAM1 | intercellular adhesion molecule 1 | 7.04 × 10−2 | 1.70 |
243645_at | NFASC | neurofascin homolog (chicken) | 2.12 × 10−3 | 2.03 | 205885_s_at | ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 2.52 × 10−1 | 1.71 |
219773_at | NOX4 | NADPH oxidase 4 | 8.60 × 10−2 | 1.80 | 216331_at | ITGA7 | integrin, alpha 7 | 1.01 × 10−2 | 3.76 |
37966_at | PARVB | parvin, beta | 4.78 × 10−10 | 2.88 | 209663_s_at | ITGA7 | integrin, alpha 7 | 4.49 × 10−2 | 3.70 |
204629_at | PARVB | parvin, beta | 2.58 × 10−8 | 2.28 | 204990_s_at | ITGB4 | integrin, beta 4 | 8.14 × 10−2 | 1.67 |
37965_at | PARVB | parvin, beta | 7.26 × 10−5 | 1.98 | 226189_at | ITGB8 | integrin, beta 8 | 2.19 × 10−2 | 1.69 |
216253_s_at | PARVB | parvin, beta | 4.90 × 10−3 | 1.80 | 220765_s_at | LIMS2 | LIM and senescent cell antigen-like domains 2 | 1.80 × 10−2 | 1.80 |
225977_at | PCDH18 | protocadherin 18 | 4.98 × 10−3 | 2.18 | 226974_at | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 4.84 × 10−2 | 2.02 |
225975_at | PCDH18 | protocadherin 18 | 1.29 × 10−2 | 1.76 | 212448_at | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 9.48 × 10−2 | 1.78 |
207011_s_at | PTK7 | PTK7 protein tyrosine kinase 7 | 3.74 × 10−3 | 2.23 | 212445_s_at | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 1.04 × 10−1 | 1.76 |
1555324_at | PTK7 | PTK7 protein tyrosine kinase 7 | 5.32 × 10−3 | 1.78 | 202150_s_at | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 3.21 × 10−3 | 1.97 |
207419_s_at | RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 1.39 × 10−2 | 2.37 | 202149_at | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 3.93 × 10−4 | 1.90 |
213603_s_at | RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 8.95 × 10−3 | 2.13 | 228635_at | PCDH10 | protocadherin 10 | 2.55 × 10−3 | 3.91 |
223168_at | RHOU | ras homolog gene family, member U | 1.13 × 10−5 | 3.13 | 223435_s_at | PCDHA1 PCDHA10 PCDHA11 PCDHA12 PCDHA13 PCDHA2 PCDHA3 PCDHA4 PCDHA5 PCDHA6 PCDHA7 PCDHA8 PCDHA9 PCDHAC1 PCDHAC2 |
protocadherin alpha 1 protocadherin alpha 10 protocadherin alpha 11 protocadherin alpha 12 protocadherin alpha 13 protocadherin alpha 2 protocadherin alpha 3 protocadherin alpha 4 protocadherin alpha 5 protocadherin alpha 6 protocadherin alpha 7 protocadherin alpha 8 protocadherin alpha 9 protocadherin alpha C, 1 protocadherin alpha C, 2 |
2.40 × 10−3 | 2.23 |
201286_at | SDC1 | syndecan 1 | 7.78 × 10−3 | 3.11 | 202565_s_at | SVIL | supervillin | 5.25 × 10−3 | 3.45 |
201287_s_at | SDC1 | syndecan 1 | 3.47 × 10−3 | 3.04 | 202566_s_at | SVIL | supervillin | 5.31 × 10−2 | 2.32 |
202898_at | SDC3 | syndecan 3 | 2.98 × 10−2 | 1.66 | 206702_at | TEK | TEK tyrosine kinase, endothelial | 4.91 × 10−4 | 3.67 |
218087_s_at | SORBS1 | sorbin and SH3 domain containing 1 | 1.05 × 10−2 | 4.48 | |||||
222513_s_at | SORBS1 | sorbin and SH3 domain containing 1 | 3.04 × 10−2 | 2.95 | |||||
208850_s_at | THY1 | Thy-1 cell surface antigen | 2.80 × 10−1 | 1.91 | |||||
213869_x_at | THY1 | Thy-1 cell surface antigen | 1.38 × 10−1 | 1.77 | |||||
208851_s_at | THY1 | Thy-1 cell surface antigen | 2.50 × 10−1 | 1.70 | |||||
217853_at | TNS3 | tensin 3 | 5.51 × 10−5 | 2.61 | |||||
217979_at | TSPAN13 | tetraspanin 13 | 1.08 × 10−4 | 4.67 | |||||
227307_at | TSPAN18 | Tetraspanin 18 | 2.78 × 10−4 | 3.95 | |||||
227236_at | TSPAN2 | tetraspanin 2 | 1.85 × 10−1 | 2.19 | |||||
214606_at | TSPAN2 | tetraspanin 2 | 1.19 × 10−1 | 1.83 | |||||
LINC Complexes | |||||||||
Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC | Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC |
203145_at | SPAG5 | sperm associated antigen 5 | 2.63 × 10−2 | 2.48 | 219888_at | SPAG4 | sperm associated antigen 4 | 8.03 × 10−2 | 1.87 |
Nucleoskeleton | |||||||||
Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC | Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC |
205436_s_at | H2AFX | H2A histone family, member X | 1.88 × 10−2 | 1.71 | 215071_s_at | HIST1H2AC | histone cluster 1, H2ac | 2.13 × 10−2 | 1.70 |
214463_x_at | HIST1H4J | histone cluster 1, H4j | 1.24 × 10−2 | 1.53 | 214455_at | HIST1H2BC | histone cluster 1, H2bc | 1.34 × 10−2 | 1.71 |
201795_at | LBR | lamin B receptor | 8.68 × 10−4 | 1.88 | 236193_at | HIST1H2BC | histone cluster 1, H2bc | 1.57 × 10−2 | 1.60 |
203276_at | LMNB1 | lamin B1 | 8.33 × 10−2 | 2.42 | 209911_x_at | HIST1H2BD | histone cluster 1, H2bd | 1.63 × 10−2 | 1.63 |
209753_s_at | TMPO | thymopoietin | 5.06 × 10−3 | 1.98 | 208527_x_at | HIST1H2BE | histone cluster 1, H2be | 4.22 × 10−3 | 1.54 |
224944_at | TMPO | thymopoietin | 5.13 × 10−3 | 1.84 | 232035_at | HIST1H4B | Histone cluster 1, H4b | 5.60 × 10−3 | 1.96 |
209754_s_at | TMPO | thymopoietin | 2.51 × 10−2 | 1.83 | 208180_s_at | HIST1H4B | Histone cluster 1, H4b | 1.34 × 10−1 | 1.59 |
203432_at | TMPO | thymopoietin | 1.02 × 10−1 | 1.64 | |||||
Secreted Factors | |||||||||
Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC | Probe Set ID | Gene Symbol | Gene Title | adj-pval | FC |
205608_s_at | ANGPT1 | angiopoietin 1 | 1.27 × 10−4 | 3.04 | 231773_at | ANGPTL1 | angiopoietin-like 1 | 3.01 × 10−2 | 2.12 |
205609_at | ANGPT1 | angiopoietin 1 | 7.38 × 10−6 | 2.97 | 224339_s_at | ANGPTL1 | angiopoietin-like 1 | 7.59 × 10−2 | 1.71 |
213001_at | ANGPTL2 | angiopoietin-like 2 | 1.03 × 10−1 | 1.50 | 239183_at | ANGPTL1 | angiopoietin-like 1 | 8.51 × 10−2 | 1.50 |
220988_s_at | C1QTNF3 | C1q and tumor necrosis factor related protein 3 | 9.99 × 10−2 | 1.78 | 221009_s_at | ANGPTL4 | angiopoietin-like 4 | 6.59 × 10−3 | 2.88 |
1405_i_at | CCL5 | chemokine (C-C motif) ligand 5 | 1.12 × 10−1 | 1.56 | 223333_s_at | ANGPTL4 | angiopoietin-like 4 | 1.80 × 10−1 | 2.11 |
203666_at | CXCL12 | chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 6.11 × 10−3 | 2.98 | 209546_s_at | APOL1 | apolipoprotein L, 1 | 1.42 × 10−1 | 1.78 |
209687_at | CXCL12 | chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 1.99 × 10−2 | 2.24 | 221087_s_at | APOL3 | apolipoprotein L, 3 | 6.19 × 10−2 | 1.83 |
222484_s_at | CXCL14 | chemokine (C-X-C motif) ligand 14 | 5.41 × 10−4 | 7.47 | 205239_at | AREG | amphiregulin | 1.14 × 10−1 | 1.75 |
218002_s_at | CXCL14 | chemokine (C-X-C motif) ligand 14 | 1.22 × 10−3 | 6.46 | 202701_at | BMP1 | bone morphogenetic protein 1 | 5.22 × 10−2 | 1.54 |
204602_at | DKK1 | dickkopf homolog 1 (Xenopus laevis) | 2.42 × 10−2 | 2.04 | 205289_at | BMP2 | bone morphogenetic protein 2 | 2.65 × 10−2 | 2.54 |
219908_at | DKK2 | dickkopf homolog 2 (Xenopus laevis) | 7.38 × 10−4 | 4.54 | 205290_s_at | BMP2 | bone morphogenetic protein 2 | 8.44 × 10−2 | 2.25 |
228952_at | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 5.77 × 10−7 | 4.95 | 211518_s_at | BMP4 | bone morphogenetic protein 4 | 1.68 × 10−2 | 4.03 |
229088_at | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 5.38 × 10−7 | 4.83 | 206176_at | BMP6 | bone morphogenetic protein 6 | 2.52 × 10−2 | 2.33 |
205066_s_at | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 3.10 × 10−5 | 4.76 | 239349_at | C1QTNF7 | C1q and tumor necrosis factor related protein 7 | 2.49 × 10−1 | 1.53 |
205065_at | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 3.78 × 10−7 | 3.82 | 202357_s_at | C2 CFB |
complement component 2 complement factor B | 3.16 × 10−3 | 3.85 |
205110_s_at | FGF13 | fibroblast growth factor 13 | 3.58 × 10−8 | 4.73 | 217767_at | C3 | complement component 3 | 2.71 × 10−1 | 2.42 |
214240_at | GAL | galanin prepropeptide | 9.61 × 10−2 | 1.59 | 208451_s_at | C4A C4B |
complement component 4A (Rodgers blood group) complement component 4B (Chido blood group) | 1.98 × 10−1 | 1.83 |
205505_at | GCNT1 | glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase) | 1.70 × 10−5 | 1.66 | 206407_s_at | CCL13 | chemokine (C-C motif) ligand 13 | 8.28 × 10−2 | 3.52 |
240509_s_at | GREM2 | gremlin 2, cysteine knot superfamily, homolog (Xenopus laevis) | 2.66 × 10−3 | 3.23 | 216598_s_at | CCL2 | chemokine (C-C motif) ligand 2 | 5.57 × 10−4 | 8.18 |
235504_at | GREM2 | gremlin 2, cysteine knot superfamily, homolog (Xenopus laevis) | 9.10 × 10−3 | 3.11 | 206508_at | CD70 | CD70 molecule | 1.14 × 10−1 | 2.44 |
220794_at | GREM2 | gremlin 2, cysteine knot superfamily, homolog (Xenopus laevis) | 2.06 × 10−2 | 2.76 | 213800_at | CFH | complement factor H | 8.63 × 10−5 | 6.48 |
206326_at | GRP | gastrin-releasing peptide | 3.05 × 10−2 | 1.59 | 215388_s_at | CFH CFHR1 |
complement factor H complement factor H-related 1 | 4.95 × 10−6 | 10.91 |
203821_at | HBEGF | heparin-binding EGF-like growth factor | 1.31 × 10−1 | 1.64 | 206910_x_at | CFHR2 | complement factor H-related 2 | 8.81 × 10−3 | 1.60 |
203819_s_at | IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 | 4.18 × 10−2 | 2.51 | 209395_at | CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 1.10 × 10−2 | 4.08 |
203820_s_at | IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 | 6.30 × 10−2 | 2.13 | 209396_s_at | CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 4.55 × 10−2 | 1.94 |
212143_s_at | IGFBP3 | insulin-like growth factor binding protein 3 | 1.26 × 10−2 | 1.54 | 206315_at | CRLF1 | cytokine receptor-like factor 1 | 8.40 × 10−3 | 3.23 |
227760_at | IGFBPL1 | insulin-like growth factor binding protein-like 1 | 3.76 × 10−3 | 1.94 | 209774_x_at | CXCL2 | chemokine (C-X-C motif) ligand 2 | 1.37 × 10−1 | 3.03 |
204773_at | IL11RA | interleukin 11 receptor, alpha | 1.36 × 10−3 | 1.97 | 207850_at | CXCL3 | chemokine (C-X-C motif) ligand 3 | 2.50 × 10−1 | 2.07 |
206172_at | IL13RA2 | interleukin 13 receptor, alpha 2 | 8.39 × 10−2 | 3.56 | 219837_s_at | CYTL1 | cytokine-like 1 | 1.99 × 10−1 | 2.02 |
227997_at | IL17RD | interleukin 17 receptor D | 9.70 × 10−2 | 1.70 | 219501_at | ENOX1 | ecto-NOX disulfide-thiol exchanger 1 | 1.82 × 10−2 | 2.35 |
222062_at | IL27RA | interleukin 27 receptor, alpha | 4.50 × 10−4 | 3.73 | 226213_at | ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 1.84 × 10−2 | 2.49 |
205926_at | IL27RA | interleukin 27 receptor, alpha | 5.58 × 10−4 | 1.67 | 205738_s_at | FABP3 | fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | 2.56 × 10−1 | 1.70 |
226218_at | IL7R | interleukin 7 receptor | 9.41 × 10−2 | 1.71 | 203980_at | FABP4 | fatty acid binding protein 4, adipocyte | 5.11 × 10−2 | 2.16 |
205798_at | IL7R | interleukin 7 receptor | 1.78 × 10−1 | 1.59 | 205117_at | FGF1 | fibroblast growth factor 1 (acidic) | 8.61 × 10−3 | 2.95 |
231798_at | NOG | noggin | 6.76 × 10−5 | 3.98 | 1552721_a_at | FGF1 | fibroblast growth factor 1 (acidic) | 1.47 × 10−2 | 2.71 |
206343_s_at | NRG1 | neuregulin 1 | 6.34 × 10−3 | 2.68 | 208240_s_at | FGF1 | fibroblast growth factor 1 (acidic) | 9.05 × 10−2 | 1.73 |
206237_s_at | NRG1 | neuregulin 1 | 7.90 × 10−2 | 2.15 | 231382_at | FGF18 | Fibroblast growth factor 18 | 1.71 × 10−1 | 2.09 |
208230_s_at | NRG1 | neuregulin 1 | 1.20 × 10−2 | 1.90 | 211029_x_at | FGF18 | fibroblast growth factor 18 | 2.54 × 10−1 | 1.64 |
204766_s_at | NUDT1 | nudix (nucleoside diphosphate linked moiety X)-type motif 1 | 2.22 × 10−5 | 1.59 | 221577_x_at | GDF15 | growth differentiation factor 15 | 3.41 × 10−2 | 2.03 |
213131_at | OLFM1 | olfactomedin 1 | 1.82 × 10−1 | 1.71 | 206614_at | GDF5 | growth differentiation factor 5 | 4.96 × 10−2 | 2.01 |
213125_at | OLFML2B | olfactomedin-like 2B | 2.17 × 10−1 | 1.93 | 201348_at | GPX3 | glutathione peroxidase 3 (plasma) | 2.15 × 10−2 | 3.24 |
218162_at | OLFML3 | olfactomedin-like 3 | 3.28 × 10−2 | 1.72 | 214091_s_at | GPX3 | glutathione peroxidase 3 (plasma) | 7.64 × 10−2 | 1.99 |
222719_s_at | PDGFC | platelet derived growth factor C | 2.01 × 10−3 | 1.61 | 209960_at | HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 7.99 × 10−2 | 3.24 |
201578_at | PODXL | podocalyxin-like | 1.11 × 10−2 | 5.15 | 210997_at | HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 2.26 × 10−2 | 2.96 |
210195_s_at | PSG1 | pregnancy specific beta-1-glycoprotein 1 | 2.14 × 10−1 | 1.82 | 210998_s_at | HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 3.94 × 10−2 | 1.80 |
208134_x_at | PSG2 | pregnancy specific beta-1-glycoprotein 2 | 1.56 × 10−3 | 3.17 | 210619_s_at | HYAL1 | hyaluronoglucosaminidase 1 | 1.86 × 10−3 | 3.19 |
203399_x_at | PSG3 | pregnancy specific beta-1-glycoprotein 3 | 8.06 × 10−3 | 3.33 | 209540_at | IGF1 | insulin-like growth factor 1 (somatomedin C) | 2.78 × 10−1 | 1.97 |
215821_x_at | PSG3 | pregnancy specific beta-1-glycoprotein 3 | 2.08 × 10−2 | 2.47 | 209542_x_at | IGF1 | insulin-like growth factor 1 (somatomedin C) | 2.03 × 10−1 | 1.57 |
211741_x_at | PSG3 | pregnancy specific beta-1-glycoprotein 3 | 1.76 × 10−2 | 2.22 | 202718_at | IGFBP2 | insulin-like growth factor binding protein 2, 36 kDa | 8.69 × 10−2 | 3.80 |
204830_x_at | PSG5 | pregnancy specific beta-1-glycoprotein 5 | 8.14 × 10−3 | 3.53 | 201508_at | IGFBP4 | insulin-like growth factor binding protein 4 | 1.12 × 10−1 | 1.68 |
209738_x_at | PSG6 | pregnancy specific beta-1-glycoprotein 6 | 7.00 × 10−3 | 3.35 | 203426_s_at | IGFBP5 | insulin-like growth factor binding protein 5 | 2.55 × 10−2 | 3.31 |
208106_x_at | PSG6 | pregnancy specific beta-1-glycoprotein 6 | 4.99 × 10−3 | 3.26 | 211958_at | IGFBP5 | insulin-like growth factor binding protein 5 | 2.16 × 10−1 | 2.76 |
209594_x_at | PSG9 | pregnancy specific beta-1-glycoprotein 9 | 5.91 × 10−3 | 3.49 | 1555997_s_at | IGFBP5 | insulin-like growth factor binding protein 5 | 1.64 × 10−1 | 2.46 |
207733_x_at | PSG9 | pregnancy specific beta-1-glycoprotein 9 | 1.20 × 10−2 | 3.03 | 203425_s_at | IGFBP5 | insulin-like growth factor binding protein 5 | 1.58 × 10−1 | 1.80 |
212187_x_at | PTGDS | prostaglandin D2 synthase 21 kDa (brain) | 5.94 × 10−3 | 1.91 | 206295_at | IL18 | interleukin 18 (interferon-gamma-inducing factor) | 3.70 × 10−2 | 3.75 |
211748_x_at | PTGDS | prostaglandin D2 synthase 21 kDa (brain) | 2.12 × 10−3 | 1.69 | 207526_s_at | IL1RL1 | interleukin 1 receptor-like 1 | 1.32 × 10−1 | 2.07 |
206631_at | PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53 kDa | 4.68 × 10−2 | 1.71 | 242809_at | IL1RL1 | Interleukin 1 receptor-like 1 | 2.38 × 10−1 | 1.60 |
211737_x_at | PTN | pleiotrophin | 7.25 × 10−2 | 3.28 | 221111_at | IL26 | interleukin 26 | 4.68 × 10−2 | 3.44 |
209465_x_at | PTN | pleiotrophin | 4.83 × 10−2 | 3.24 | 209821_at | IL33 | interleukin 33 | 1.79 × 10−1 | 1.50 |
209466_x_at | PTN | pleiotrophin | 1.03 × 10−1 | 2.42 | 205207_at | IL6 | interleukin 6 (interferon, beta 2) | 2.42 × 10−4 | 3.20 |
209897_s_at | SLIT2 | slit homolog 2 (Drosophila) | 1.55 × 10−2 | 1.98 | 204863_s_at | IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 1.97 × 10−2 | 1.99 |
205016_at | TGFA | transforming growth factor, alpha | 4.19 × 10−2 | 3.27 | 211000_s_at | IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 1.21 × 10−2 | 1.88 |
203085_s_at | TGFB1 | transforming growth factor, beta 1 | 7.50 × 10−3 | 1.60 | 204926_at | INHBA | inhibin, beta A | 1.44 × 10−2 | 2.47 |
236561_at | TGFBR1 | Transforming growth factor, beta receptor 1 | 4.05 × 10−2 | 1.71 | 210511_s_at | INHBA | inhibin, beta A | 4.64 × 10−3 | 2.42 |
203887_s_at | THBD | thrombomodulin | 2.94 × 10−1 | 2.27 | 205266_at | LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 7.91 × 10−2 | 2.44 |
239336_at | THBS1 | Thrombospondin 1 | 1.84 × 10−1 | 1.58 | 219181_at | LIPG | lipase, endothelial | 3.51 × 10−2 | 2.89 |
227420_at | TNFAIP8L1 | tumor necrosis factor, alpha-induced protein 8-like 1 | 3.38 × 10−3 | 1.71 | 205381_at | LRRC17 | leucine rich repeat containing 17 | 2.67 × 10−4 | 18.57 |
219478_at | WFDC1 | WAP four-disulfide core domain 1 | 3.17 × 10−2 | 5.38 | 216320_x_at | MST1 | macrophage stimulating 1 (hepatocyte growth factor-like) | 1.05 × 10−1 | 1.53 |
221029_s_at | WNT5B | wingless-type MMTV integration site family, member 5B | 5.20 × 10−4 | 2.39 | 231361_at | NLGN1 | Neuroligin 1 | 4.86 × 10−2 | 3.33 |
223537_s_at | WNT5B | wingless-type MMTV integration site family, member 5B | 2.99 × 10−2 | 1.65 | 205893_at | NLGN1 | neuroligin 1 | 7.72 × 10−2 | 3.23 |
204501_at | NOV | nephroblastoma overexpressed gene | 2.01 × 10−2 | 2.95 | |||||
214321_at | NOV | nephroblastoma overexpressed gene | 1.69 × 10−2 | 2.60 | |||||
217525_at | OLFML1 | olfactomedin-like 1 | 5.70 × 10−2 | 3.66 | |||||
213075_at | OLFML2A | olfactomedin-like 2A | 1.64 × 10−2 | 2.12 | |||||
205729_at | OSMR | oncostatin M receptor | 6.53 × 10−2 | 1.71 | |||||
224942_at | PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 2.20 × 10−2 | 1.88 | |||||
1559400_s_at | PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 3.28 × 10−2 | 1.84 | |||||
201981_at | PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 3.78 × 10−2 | 1.74 | |||||
224940_s_at | PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 1.72 × 10−2 | 1.73 | |||||
224941_at | PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 1.36 × 10−2 | 1.69 | |||||
228128_x_at | PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 2.13 × 10−2 | 1.64 | |||||
205560_at | PCSK5 | proprotein convertase subtilisin/kexin type 5 | 2.21 × 10−3 | 2.70 | |||||
213652_at | PCSK5 | Proprotein convertase subtilisin/kexin type 5 | 5.18 × 10−4 | 2.66 | |||||
205559_s_at | PCSK5 | proprotein convertase subtilisin/kexin type 5 | 1.23 × 10−3 | 2.52 | |||||
227759_at | PCSK9 | proprotein convertase subtilisin/kexin type 9 | 2.34 × 10−2 | 1.97 | |||||
216867_s_at | PDGFA | platelet-derived growth factor alpha polypeptide | 2.46 × 10−2 | 1.97 | |||||
222860_s_at | PDGFD | platelet derived growth factor D | 1.50 × 10−1 | 1.57 | |||||
1555778_a_at | POSTN | periostin, osteoblast specific factor | 4.41 × 10−3 | 4.30 | |||||
214981_at | POSTN | periostin, osteoblast specific factor | 2.20 × 10−3 | 2.96 | |||||
210809_s_at | POSTN | periostin, osteoblast specific factor | 8.30 × 10−3 | 2.47 | |||||
207808_s_at | PROS1 | protein S (alpha) | 3.88 × 10−3 | 1.51 | |||||
213421_x_at | PRSS3 | protease, serine, 3 | 2.41 × 10−2 | 2.68 | |||||
210367_s_at | PTGES | prostaglandin E synthase | 3.17 × 10−4 | 4.21 | |||||
207388_s_at | PTGES | prostaglandin E synthase | 4.23 × 10−2 | 2.51 | |||||
224950_at | PTGFRN | prostaglandin F2 receptor negative regulator | 4.86 × 10−2 | 1.78 | |||||
211892_s_at | PTGIS | prostaglandin I2 (prostacyclin) synthase | 4.91 × 10−2 | 2.06 | |||||
210702_s_at | PTGIS | prostaglandin I2 (prostacyclin) synthase | 1.13 × 10−1 | 1.70 | |||||
208131_s_at | PTGIS | prostaglandin I2 (prostacyclin) synthase | 2.43 × 10−2 | 1.67 | |||||
211756_at | PTHLH | parathyroid hormone-like hormone | 6.78 × 10−2 | 3.45 | |||||
206300_s_at | PTHLH | parathyroid hormone-like hormone | 7.08 × 10−2 | 2.86 | |||||
210355_at | PTHLH | parathyroid hormone-like hormone | 1.70 × 10−1 | 2.21 | |||||
206157_at | PTX3 | pentraxin-related gene, rapidly induced by IL-1 beta | 1.47 × 10−4 | 2.21 | |||||
201482_at | QSOX1 | quiescin Q6 sulfhydryl oxidase 1 | 2.19 × 10−3 | 1.68 | |||||
223824_at | RNLS | renalase, FAD-dependent amine oxidase | 5.18 × 10−4 | 1.74 | |||||
204035_at | SCG2 | secretogranin II (chromogranin C) | 2.66 × 10−2 | 2.56 | |||||
205475_at | SCRG1 | scrapie responsive protein 1 | 6.88 × 10−7 | 7.73 | |||||
213716_s_at | SECTM1 | secreted and transmembrane 1 | 3.32 × 10−2 | 3.29 | |||||
203071_at | SEMA3B | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B | 6.35 × 10−2 | 2.54 | |||||
203788_s_at | SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 6.34 × 10−4 | 2.51 | |||||
203789_s_at | SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 3.13 × 10−3 | 1.64 | |||||
33323_r_at | SFN | stratifin | 1.80 × 10−1 | 2.42 | |||||
223122_s_at | SFRP2 | secreted frizzled-related prot 2 | 2.86 × 10−1 | 2.33 | |||||
204051_s_at | SFRP4 | secreted frizzled-related prot 4 | 4.79 × 10−2 | 4.23 | |||||
204052_s_at | SFRP4 | secreted frizzled-related prot 4 | 1.56 × 10−1 | 2.58 | |||||
210665_at | TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 4.02 × 10−2 | 3.69 | |||||
210664_s_at | TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 2.35 × 10−2 | 3.50 | |||||
209676_at | TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 2.96 × 10−2 | 3.35 | |||||
213258_at | TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 2.61 × 10−2 | 3.24 | |||||
228121_at | TGFB2 | transforming growth factor, beta 2 | 1.08 × 10−6 | 5.13 | |||||
209909_s_at | TGFB2 | transforming growth factor, beta 2 | 5.47 × 10−5 | 3.64 | |||||
204731_at | TGFBR3 | transforming growth factor, beta receptor III | 2.06 × 10−1 | 1.70 | |||||
203083_at | THBS2 | thrombospondin 2 | 4.84 × 10−6 | 2.83 | |||||
202644_s_at | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 1.61 × 10−3 | 3.88 | |||||
202643_s_at | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 4.35 × 10−3 | 3.52 | |||||
206025_s_at | TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 1.57 × 10−2 | 2.29 | |||||
206026_s_at | TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 3.57 × 10−2 | 2.15 | |||||
210260_s_at | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 5.99 × 10−4 | 2.01 | |||||
208296_x_at | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 1.11 × 10−3 | 1.94 | |||||
235737_at | TSLP | thymic stromal lymphopoietin | 1.72 × 10−1 | 2.02 | |||||
210513_s_at | VEGFA | vascular endothelial growth factor A | 9.18 × 10−2 | 1.57 | |||||
205648_at | WNT2 | wingless-type MMTV integration site family member 2 | 2.83 × 10−1 | 2.08 | |||||
202643_s_at | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 4.35 × 10−3 | 3.52 | |||||
206025_s_at | TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 1.57 × 10−2 | 2.29 | |||||
206026_s_at | TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 3.57 × 10−2 | 2.15 | |||||
210260_s_at | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 5.99 × 10−4 | 2.01 | |||||
208296_x_at | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 1.11 × 10−3 | 1.94 | |||||
235737_at | TSLP | thymic stromal lymphopoietin | 1.72 × 10−1 | 2.02 | |||||
210513_s_at | VEGFA | vascular endothelial growth factor A | 9.18 × 10−2 | 1.57 | |||||
205648_at | WNT2 | wingless-type MMTV integration site family member 2 | 2.83 × 10−1 | 2.08 |